Blogs

Proton Therapy for Pediatric Cancer [Webinar]
by OncoLink Editorial Team
September 23, 2014

Don't Assume You Understand
by Bob Riter
July 29, 2015

Related News

Sarcoma Characteristics ID'd in TP53 Mutation Carriers

Aug 22, 2011

Rhabdomyosarcoma likely <5 years, osteosarcoma at any age, leiomyosarcoma >20 years


Cixutumumab Tolerated for Pediatric Refractory Solid Tumors

Dec 22, 2011

Recommended phase II pediatric dose is 9 mg/kg intravenously once per week


Receptor in Osteosarcoma May Provide Treatment Approach

Jul 29, 2015

Interleukin-11 receptor alpha is highly expressed in primary osteosarcoma and lung metastases